Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31473116 | 1.00 | F2 (0.69) | F2MEN1KMT2AHSD17B3NPC1 | |
| SCHEMBL29367779 | 0.91 | F2 (0.60) | F2NPC1RAB9A | |
| SCHEMBL7187176 | 0.91 | F2 (0.60) | F2NPC1RAB9A | |
| SCHEMBL7198317 | 0.91 | F2 (0.63) | F2MEN1KMT2ANPC1RAB9A | |
| Methyl Alcohol SCHEMBL28295371 | 0.90 | F2 (0.58) | F2NPC1RAB9A | |
| SCHEMBL7194539 | 0.83 | MEN1 (0.55) | F2MEN1KMT2AHSD17B3NPC1 | |
| SCHEMBL4841064 | 0.83 | POLB (0.62) | F2MEN1KMT2A | |
| SCHEMBL4316064 | 0.82 | POLB (0.70) | F2NPC1RAB9A | |
| SCHEMBL31237171 | 0.82 | POLB (0.70) | F2NPC1RAB9A | |
| SCHEMBL435484 | 0.81 | F2 (0.49) | F2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030065039-A1 | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones | STATENS SERUM INSTITUTE (DK) | 2003-04-03 | — | — | US | claimed |
| CN-106265612-A | Lourerin C application in preparation preventing and treating central nervous system disease medicine | 沈阳药科大学 | 2017-01-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065039-A1 | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones | AKR1C3, AKR1C1, AKR1A1 | F2 499/4885MEN1 3878/4885KMT2A 4485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.